Application of CAPA to the Device Sterilization Process

Sponsored by ComplianceOnline
March 14-15, 2012 - Irvine, California

Early Bird Registration, Until January 20th: Register Here! $1,399.00
Regular Registration, January  21st - February 9th: Register Here! $1,599.00
Regular Registration, February 10th - February 29th: Register Here! $1,799.00
Regular Registration, March 1st and Later: Register Here! $1,999.00

Your tuition fee includes the workshop, all course materials, and lunch for two days. Venue:  To be announced. Irvine, CA.


Description

Do you use a Contract Sterilizer for your medical device sterilization? Are you not an expert in industrial sterilization? If you answered “yes” to either of these questions, this seminar is a must for you and your team members.

The FDA and your Notified Body will look to you, the medical device manufacturer, for the answers to deficiencies in the sterilization process whether sterilization is performed at your location or at a contract sterilizer.

In this seminar you will be provided a basic understanding of radiation and EO sterilization processes and validation methods associated with both methods. Typical and non-typical sterilization deficiencies will be reviewed and insight provided on the investigation needed to provide root cause to the deficiency and lead to effective CAPA.

CAPA will also be reviewed in detail to provide an understanding of what CAPA is, the regulations and standards involved, and when to apply CAPA. A hands on workshop is held at the end of the sessions where the attendee will be provided “real case” deficiencies and will apply information received during the seminar, ensuring a full understanding of applying CAPA for your sterilization processes.

Course Outlines

Day 1

  • Introduction to Industrial Sterilization
  • Basic terms and definitions
  • EO sterilization and Validation processes
  • Documenting the EO Validation
  • Maintaining EO Validation
  • Typical deficiencies in the EO Process and Validation
  • Critical and noncritical deficiencies in the EO Process
  • Radiation Sterilization and Validation processes
  • Determining sterilization dose
  • Process validation
  • Maintaining validated sterilization dose
  • Documenting the Radiation Validation
  • Typical deficiencies in the Radiation Process and Validation
  • Critical and non critical deficiencies in the Radiation Process
  • When you should initiate CAPA with your contract sterilizer

Day 2

  • Introduction to CAPA
  • Applicable regulations and standards
  • Why CAPA
  • Defining when to move deficiency to CAPA
  • Determining Root Cause
  • Determining Actions to Prevent Recurrence
  • CAPA tools
  • Workshop (1/2 day)
    • utilizing CAPA to solve sterilization deficiencies
    • utilizing CAPA to solve typical quality deficiencies - attendees will present results in workshop
Who Will Benefit

This course benefits anyone involved in ensuring quality for medical devices and is ideal for quality and engineering professionals working in the medical device sector.

  • QA personnel
  • CAPA team members
  • SA personnel
  • Quality Engineers
  • Operations Managers
Instructor Profile

Ms. Foster began her medical device career at Sterigenics International in 1989. Throughout her tenure, Ms. Foster has held various quality assurance positions at both the facility and Corporate levels where she served as Sterigenics Vice President of Quality Assurance from 1997 – 2004 and as Vice President SteriPro Labs & Consulting from 2004-2011. Most recently she has started her own firm, Adiuvo QS & SA Consulting and has a joint relationship with Blue Skies LLC.

Ms. Foster is an Executive Committee Member of the AAMI Sterilization Standards Board (invitation only), a member of the AAMI Sterilization Standards Committee (invitation only), serves as Co-Chair and ISO delegate to AAMI/ISO/TC 198/WG2 Radiation Sterilization Working Group, has served as co-chair for the AAMI Radiation Process Control Task Group, which developed TIR 29, Guide for Process Control in Radiation Sterilization, and is also an active member of several other AAMI Sterilization Working groups.

Ms. Foster has been a presenter at numerous industry and FDA training seminars throughout the United States. She holds a Bachelor of Science in Food and Nutrition from Mississippi University for Women and a Masters of Science in Food Technology from Mississippi State University. Ms. Foster's areas of expertise include sterilization, sterilization validation, regulatory compliance, Quality System Regulation, quality systems management, CAPA, and FEMA.

Ms. Celeste Amlen is an experienced Quality Executive Professional with over 20 years experience in the Medical Device and In-vitro Diagnostics Industries.

A proven Quality Assurance leader with international work experience from several Fortune 500 companies. A successful track record in continuously improving performing Quality Assurance organizations. A catalyst for turning around ailing organizations through the implementation of new organizational structures, system implementations as well as execution of business process transformation projects.

Extensive experience working in a fast paced, high-energy work environment on high visibility projects, with the last eleven years dedicated to Quality Systems and Project Management in the Medical Device and In-vitro Diagnostics industry.

Celeste Amlen has extensive experience interfacing with the FDA in compliance related matters; facility inspections, responding to FDA 483 and Warning Letters, Medical Device Reporting. Setting up quality systems in conformance to ISO13485 and 21 CFRs.

REGISTER

 

Early Bird Registration, Until January 20th:
Register Here! $1,399.00

Regular Registration, January  21st - February 9th: Register Here! $1,599.00

Regular Registration, February 10th - February 29th: Register Here! $1,799.00

Regular Registration, March 1st and Later:
Register Here! $1,999.00

Your tuition fee includes the workshop, all course materials, and lunch for two days.

 

Upcoming Live FDA Conferences

Enhancing Drug Bioavailability & Solubility
Boston, MA
Jan. 25-26, 2012

Understanding and Implementing the Medical Device Directive
San Diego, CA
Jan. 26-27, 2012

Statistical Considerations for ICH Guidelines
San Francisco, CA
Jan. 30-31, 2012

Computer System Validation - Reduce Costs and Avoid 483s
Scottsdale, AZ
Feb. 2-3, 2012

The A to Z's of Microbial Control, Monitoring and Validation of Pharmaceutical Water Systems
San Francisco, CA
Feb. 22-23, 2012

2nd Patient Adherence Summit
Philadelphia, PA
Feb. 23-24, 2012

2nd Annual Maximizing Relationships with Nurse Practitioners and Physician Assistants Summit
Philadelphia, PA
Feb. 23-24, 2012

6th Annual Clinical Billing & Research Compliance
Las Vegas, NV
Mar. 4-6, 2012

Quality Oversight for Medical Device Manufacturing Summit
Los Angeles, CA
Mar. 12-13, 2012

3rd Patient Engagement Technologies in Clinical Trials
Philadelphia, PA
Mar. 19-21, 2012

6th Forecasting and Optimizing the Clinical Supply Chain
Philadelphia, PA
Mar. 19-21, 2012

3rd Annual Clinical Site Feasibility, Selection and Startup
Philadelphia, PA
Mar. 19-21, 2012

5th Lean Sigma & Kaizen for Pharma R&D
Philadelphia, PA
Mar. 19-21, 2012

8th Latin America Clinical Trials Conference
Philadelphia, PA
Mar. 20-21, 2012

Transferring a Medical OEM Molding and Assembly Operation to a Manufacturer with Validated Systems and Processes
Chicago, IL
March 29-30, 2012


Cancellation Policy:
Written cancellations received at least 15 calendar days prior to the start date of the event will receive a refund — less a $150 administration fee. No cancellations will be accepted — nor refunds issued — within 15 calendar days from the start date of the event. A credit for the amount paid may be transferred to any future ComplianceOnline event. Substitutions may be made at any time. No-shows will be charged the full amount. In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice. 

SPREAD THE NEWS

Please forward this invitation to colleagues who may benefit from participating.

This message is sent to you by FDANewswatch